Literature DB >> 17570216

Protease-activated receptor 2, dipeptidyl peptidase I, and proteases mediate Clostridium difficile toxin A enteritis.

Graeme S Cottrell1, Silvia Amadesi, Stella Pikios, Eric Camerer, J Adam Willardsen, Brett R Murphy, George H Caughey, Paul J Wolters, Shaun R Coughlin, Anders Peterson, Wolfgang Knecht, Charalabos Pothoulakis, Nigel W Bunnett, Eileen F Grady.   

Abstract

BACKGROUND & AIMS: We studied the role of protease-activated receptor 2 (PAR(2)) and its activating enzymes, trypsins and tryptase, in Clostridium difficile toxin A (TxA)-induced enteritis.
METHODS: We injected TxA into ileal loops in PAR(2) or dipeptidyl peptidase I (DPPI) knockout mice or in wild-type mice pretreated with tryptase inhibitors (FUT-175 or MPI-0442352) or soybean trypsin inhibitor. We examined the effect of TxA on expression and activity of PAR(2) and trypsin IV messenger RNA in the ileum and cultured colonocytes. We injected activating peptide (AP), trypsins, tryptase, and p23 in wild-type mice, some pretreated with the neurokinin 1 receptor antagonist SR140333.
RESULTS: TxA increased fluid secretion, myeloperoxidase activity in fluid and tissue, and histologic damage. PAR(2) deletion decreased TxA-induced ileitis, reduced luminal fluid secretion by 20%, decreased tissue and fluid myeloperoxidase by 50%, and diminished epithelial damage, edema, and neutrophil infiltration. DPPI deletion reduced secretion by 20% and fluid myeloperoxidase by 55%. In wild-type mice, FUT-175 or MPI-0442352 inhibited secretion by 24%-28% and tissue and fluid myeloperoxidase by 31%-71%. Soybean trypsin inhibitor reduced secretion to background levels and tissue myeloperoxidase by up to 50%. TxA increased expression of PAR(2) and trypsin IV in enterocytes and colonocytes and caused a 2-fold increase in Ca(2+) responses to PAR(2) AP. AP, tryptase, and trypsin isozymes (trypsin I/II, trypsin IV, p23) caused ileitis. SR140333 prevented AP-induced ileitis.
CONCLUSIONS: PAR(2) and its activators are proinflammatory in TxA-induced enteritis. TxA stimulates existing PAR(2) and up-regulates PAR(2) and activating proteases, and PAR(2) causes inflammation by neurogenic mechanisms.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17570216      PMCID: PMC2366898          DOI: 10.1053/j.gastro.2007.03.101

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  51 in total

1.  Agonists of proteinase-activated receptor 2 induce inflammation by a neurogenic mechanism.

Authors:  M Steinhoff; N Vergnolle; S H Young; M Tognetto; S Amadesi; H S Ennes; M Trevisani; M D Hollenberg; J L Wallace; G H Caughey; S E Mitchell; L M Williams; P Geppetti; E A Mayer; N W Bunnett
Journal:  Nat Med       Date:  2000-02       Impact factor: 53.440

2.  Deletion of neutral endopeptidase exacerbates intestinal inflammation induced by Clostridium difficile toxin A.

Authors:  K S Kirkwood; N W Bunnett; J Maa; I Castagliolo; B Liu; N Gerard; J Zacks; C Pothoulakis; E F Grady
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2001-08       Impact factor: 4.052

3.  Proteinase-activated receptor-2 and hyperalgesia: A novel pain pathway.

Authors:  N Vergnolle; N W Bunnett; K A Sharkey; V Brussee; S J Compton; E F Grady; G Cirino; N Gerard; A I Basbaum; P Andrade-Gordon; M D Hollenberg; J L Wallace
Journal:  Nat Med       Date:  2001-07       Impact factor: 53.440

4.  Highly efficient and versatile synthesis of libraries of constrained beta-strand mimetics.

Authors:  C O Ogbu; M N Qabar; P D Boatman; J Urban; J P Meara; M D Ferguson; J Tulinsky; C Lum; S Babu; M A Blaskovich; H Nakanishi; F Ruan; B Cao; R Minarik; T Little; S Nelson; M Nguyen; A Gall; M Kahn
Journal:  Bioorg Med Chem Lett       Date:  1998-09-08       Impact factor: 2.823

5.  Agonists of proteinase-activated receptor-2 stimulate upregulation of intercellular cell adhesion molecule-1 in primary human keratinocytes via activation of NF-kappa B.

Authors:  Jörg Buddenkotte; Christopher Stroh; Ingo H Engels; Corinna Moormann; Victoria M Shpacovitch; Stephan Seeliger; Nathalie Vergnolle; Dietmar Vestweber; Thomas A Luger; Klaus Schulze-Osthoff; Martin Steinhoff
Journal:  J Invest Dermatol       Date:  2005-01       Impact factor: 8.551

6.  Neurokinin-1 (NK-1) receptor is required in Clostridium difficile- induced enteritis.

Authors:  I Castagliuolo; M Riegler; A Pasha; S Nikulasson; B Lu; C Gerard; N P Gerard; C Pothoulakis
Journal:  J Clin Invest       Date:  1998-04-15       Impact factor: 14.808

7.  Neurotensin is a proinflammatory neuropeptide in colonic inflammation.

Authors:  I Castagliuolo; C C Wang; L Valenick; A Pasha; S Nikulasson; R E Carraway; C Pothoulakis
Journal:  J Clin Invest       Date:  1999-03       Impact factor: 14.808

8.  Genetic deficiency in the chemokine receptor CCR1 protects against acute Clostridium difficile toxin A enteritis in mice.

Authors:  Olivier Morteau; Ignazio Castagliuolo; Andreas Mykoniatis; Jeff Zacks; Michael Wlk; Bao Lu; Charalabos Pothoulakis; Norma P Gerard; Craig Gerard
Journal:  Gastroenterology       Date:  2002-03       Impact factor: 22.682

9.  Substance P receptor expression in intestinal epithelium in clostridium difficile toxin A enteritis in rats.

Authors:  C Pothoulakis; I Castagliuolo; S E Leeman; C C Wang; H Li; B J Hoffman; E Mezey
Journal:  Am J Physiol       Date:  1998-07

10.  Mast cell dipeptidyl peptidase I mediates survival from sepsis.

Authors:  Jon Mallen-St Clair; Christine T N Pham; S Armando Villalta; George H Caughey; Paul J Wolters
Journal:  J Clin Invest       Date:  2004-02       Impact factor: 14.808

View more
  20 in total

Review 1.  Targeting proteinase-activated receptors: therapeutic potential and challenges.

Authors:  Rithwik Ramachandran; Farshid Noorbakhsh; Kathryn Defea; Morley D Hollenberg
Journal:  Nat Rev Drug Discov       Date:  2012-01-03       Impact factor: 84.694

2.  Activation of protease activated receptor 2 by exogenous agonist exacerbates early radiation injury in rat intestine.

Authors:  Junru Wang; Marjan Boerma; Ashwini Kulkarni; Morley D Hollenberg; Martin Hauer-Jensen
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-07-15       Impact factor: 7.038

Review 3.  Mast cell peptidases: chameleons of innate immunity and host defense.

Authors:  Neil N Trivedi; George H Caughey
Journal:  Am J Respir Cell Mol Biol       Date:  2009-11-20       Impact factor: 6.914

4.  Cathepsin S is activated during colitis and causes visceral hyperalgesia by a PAR2-dependent mechanism in mice.

Authors:  Fiore Cattaruzza; Victoria Lyo; Ella Jones; David Pham; James Hawkins; Kimberley Kirkwood; Eduardo Valdez-Morales; Charles Ibeakanma; Stephen J Vanner; Matthew Bogyo; Nigel W Bunnett
Journal:  Gastroenterology       Date:  2011-07-28       Impact factor: 22.682

5.  Role of enteric nerves in immune-mediated changes in protease-activated receptor 2 effects on gut function.

Authors:  T Shea-Donohue; L Notari; J Stiltz; R Sun; K B Madden; J F Urban; A Zhao
Journal:  Neurogastroenterol Motil       Date:  2010-07-11       Impact factor: 3.598

6.  Rotavirus infection induces glycan availability to promote ileum-specific changes in the microbiome aiding rotavirus virulence.

Authors:  Melinda A Engevik; Lori D Banks; Kristen A Engevik; Alexandra L Chang-Graham; Jacob L Perry; Diane S Hutchinson; Nadim J Ajami; Joseph F Petrosino; Joseph M Hyser
Journal:  Gut Microbes       Date:  2020-05-13

7.  Modulating human proteinase activated receptor 2 with a novel antagonist (GB88) and agonist (GB110).

Authors:  J Y Suen; G D Barry; R J Lohman; M A Halili; A J Cotterell; G T Le; D P Fairlie
Journal:  Br J Pharmacol       Date:  2012-03       Impact factor: 8.739

Review 8.  Mast cell proteases as protective and inflammatory mediators.

Authors:  George H Caughey
Journal:  Adv Exp Med Biol       Date:  2011       Impact factor: 2.622

Review 9.  Gastrointestinal roles for proteinase-activated receptors in health and disease.

Authors:  A Kawabata; M Matsunami; F Sekiguchi
Journal:  Br J Pharmacol       Date:  2007-11-12       Impact factor: 8.739

Review 10.  Enteric bacterial proteases in inflammatory bowel disease- pathophysiology and clinical implications.

Authors:  Ian M Carroll; Nitsan Maharshak
Journal:  World J Gastroenterol       Date:  2013       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.